Abstract:Aim: The influence of the physiochemical properties of dendrimer nanoparticles on cardiac contractility and hemodynamics are not known. Herein, we investigated (a) the effect of polyamidoamine (PAMAM) dendrimer generation (G7, G6, G5, G4 and G3) and surface chemistry (-NH2, -COOH and -OH) on cardiac function in mammalian hearts following ischemia-reperfusion (I/R) injury, and (b) determined if any PAMAM-induced cardiotoxicity could be mitigated by Angiotensin-(1-7) (Ang-(1-7), a cardioprotective agent. Methods: Hearts isolated from male Wistar rats underwent regional I/R and/or treatment with different PAMAM dendrimers, Ang-(1-7) or its MAS receptors antagonists. Thirty minutes of regional ischemia through ligation of the left anterior descending coronary artery was followed by 30 min of reperfusion. All treatments were initiated 5 min prior to reperfusion and maintained during the first 10 min of reperfusion. Cardiac function parameters for left ventricular contractility, hemodynamics and vascular dynamics data were acquired digitally, whereas cardiac enzymes and infarct size were used as measures of cardiac injury. Results: Treatment of isolated hearts with increasing doses of G7 PAMAM dendrimer progressively exacerbated recovery of cardiac contractility and hemodynamic parameters post-I/R injury. Impairment of cardiac function was progressively less on decreasing dendrimer generation with G3 exhibiting little or no cardiotoxicity. Cationic PAMAMs (-NH2) were more toxic than anionic (-COOH), with neutral PAMAMs (-OH) exhibiting the least cardiotoxicity. Cationic G7 PAMAM-induced cardiac dysfunction was significantly reversed by Ang-(1-7) administration. These cardioprotective effects of Ang-(1-7) were significantly revoked by administration of the MAS receptor antagonists, A779 and D-Pro7-Ang-(1-7). Conclusions: PAMAM dendrimers can impair the recovery of hearts from I/R injury in a dose-, dendrimer-generation-(size) and surface-charge dependent manner. Importantly, PAMAM-induced cardiotoxicity could be mitigated by Ang-(1-7) acting through its MAS receptor. Thus, this study highlights the activation of Ang-(1-7)/Mas receptor axis as a novel strategy to overcome dendrimer-induced cardiotoxicity.

Effect of Poly(amidoamine) Dendrimers on the Structure and Activity of Immune Molecules

Effects of poly(amidoamine) dendrimers on the structure and function of key blood components

Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.

Are PAMAM dendrimers safe for ocular applications? -- Toxicological evaluation in ocular cells and intraocular tissues

Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells.

Reducing the Cytotoxity of Poly(amidoamine) Dendrimers by Modification of a Single Layer of Carboxybetaine.

The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress.

In vitro dose-response effects of poly(amidoamine) dendrimers [amino-terminated and surface-modified with N-(2-hydroxydodecyl) groups] and quantitative determination by a liquid chromatography-hybrid quadrupole/time-of-flight mass spectrometry based method

Quantitative assessment of surface functionality effects on microglial uptake and retention of PAMAM dendrimers

Toxicity of polyamidoamine dendrimers in vivo

AN OVERVIEW OF POLYAMIDOAMINE DENDRIMERS: STRUCTURE, PHYSICAL PROPERTIES, AND BIOMEDICAL APPLICATIONS

Comparison of Generation 3 Polyamidoamine Dendrimer and Generation 4 Polypropylenimine Dendrimer on Drug Loading, Complex Structure, Release Behavior, and Cytotoxicity.

[Impact of Polyamidoamine Dendrimer Liposome on the Cellular Uptake and Cytotoxicity of Colonic Cancer Cells].

Mitigating Cardiotoxicity of Dendrimers: Angiotensin-(1-7) via Its Mas Receptor Ameliorates PAMAM-Induced Cardiac Dysfunction in the Isolated Mammalian Heart

Studies on PAMAM Dendrimers As an Efficient Gene Delivery Vector

Polyamidoamine Dendrimers Surface-Engineered with Biomimetic Phosphorylcholine As Potential Drug Delivery Carriers

Surface Engineering of Poly(Amido-Amine) Via Biomimetic Phosphorylcholine

Synthesis and application of poly(amidoamine) functional biomedical materials in the field of biomedicine over the past decade

Studies on Polyamidoamine Dendrimers As Efficient Gene Delivery Vector

Progress in research of polyamidoamine dendrimers as gene carriers

Cell membrane disintegration and extracellular vesicle release in a model of different size and charge PAMAM dendrimers effects on cultured endothelial cells